An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients-Reference-Cited by-同舟云学术

An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients

Published:2017-07 Issue: Volume:470 Page:8-13
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Rousset Marine,Titier Karine,Bouchet Stephane,Dutriaux Caroline,Pham-Ledard Anne,Prey Sorilla,Canal-Raffin Mireille,Molimard Mathieu

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference32 articles.

1. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials;Korn;J. Clin. Oncol.,2008

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032;Rubinstein;J. Transl. Med.,2010

4. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N. Engl. J. Med.,2012

5. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma;Long;N. Engl. J. Med.,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MonoTip C18 pipette tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry enables rapid and automated therapeutic drug monitoring of tyrosine kinase inhibitors;Arabian Journal of Chemistry;2024-10

2. LC‐ESI‐MS/MS method validation for simultaneous quantification of FDA‐approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics;Biomedical Chromatography;2024-09-05

3. New stability indicating RP-HPLC methods for the determination of related substances and assay of trametinib acetic acid: a mass balance approach;Analytical Sciences;2024-07-30

4. Electrochemical Determination of Anti‐Cancer Drug Dabrafenib with High Sensitivity Using Multi‐Walled Carbon Nano Tubes Modified Glassy Carbon Electrode;ChemistrySelect;2024-06-18

5. Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples;Microchemical Journal;2024-06